|
|
Article: Clinic Roundup.
- Article from:
- BIOWORLD Today
- Article date:
- November 29, 2007
CopyrightCOPYRIGHT 2007 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
7TM Pharma A/S, of Horsholm, Denmark, said data from a double-blind, placebo-controlled, dose-ranging Phase I/II obesity trial showed that Obinepitide effectively inhibits food intake. Obinepitide is an analogue of two hormones involved in appetite regulation. Data from a Phase II trial are expected in the first quarter of 2008.
Ardea Biosciences, of Carlsbad, Calif., said it has started a new clinical development program directed toward the treatment of gout, a painful and debilitating disease caused by abnormally elevated levels of uric acid in the blood stream.
BioAlliance Pharma SA, of Paris, said it has extended its ongoing acyclovir Lauriad ...